NOVAVAX INC: cash_and_equivalents
| Value | {"amount": 573630000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2024-09-30) |
| Status | current |
| Entity | NOVAVAX INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:41:04.438994+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4fbd9d11-44d7-483b-b335-a6b3f9715d9a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001000694-24-000043Retrieved: 2026-08-19T09:41:04.438994+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001000694/cash-and-equivalents/2024-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4fbd9d11-44d7-483b-b335-a6b3f9715d9a
History
- no predecessors — first report